You are here: Ongoing Projects – Philippine Council for Health Research and Development
Predictive Value of 24-Hour Bilirubin in Developing Hyperbilirubinemia among Term Infants in a Multi-Center Study in the Philippines
OHRPA
Cataloging Possible Philippine Strains of Zika and African Swine Fever Viruses and Coconut Cadang-Cadang Viroid through Genome Sequencing
ITDI
Re-emerging and Emerging Diseases (RED)
Assessment of Diagnostic Algorithms and Tools for Multidrug Resistant and Drug Sensitive Tuberculosis in the Philippines Part II (TB-FIT 2)
De La Salle Medical and Health Sciences Institute (DLSMHSI)
OHRPA
Long Term outcomes of Diagnosed Tuberculosis Cases in the Philippines
National Institutes of Health - UP Manila
OHRPA
Community Approach to Control and Halt Drug-Resistant TB (COACH DRTB)
De La Salle Medical and Health Sciences Institute (DLSMHSI)
OHRPA
Prospective Urban and Rural Epidemiologic (PURE) Study
Philippine General Hospital
OHRPA
The International Polycap Study 3 (TIPS3)
Philippine General Hospital
OHRPA
The Philippine COPD Profile and Survival Study (CPASS): A Multicenter, Prospective Cohort, Observational Study
Philippine College of Chest Physicians
OHRPA
Virology and Vaccine Institue of the Philippines (VIP) Program: Project 3. Detection of food and water-borne bacterial pathogens using phage-based diagnostics
ITDI
Re-emerging and Emerging Diseases (RED)
Virology and Vaccine Institute of the Philippines (VIP) Program: Project 2. Combination Therapy: Lytic Bacteriophages and Plant Extracts against Multidrug-Resistant Bacteria
ITDI
Re-emerging and Emerging Diseases (RED)
Virology and Vaccine Institute of the Philippines (VIP) Program: Project 1. Isolation and purification of Philippine Common Viruses with medical importance and pandemic potential for Antigen-Antibody Studies
ITDI
Re-emerging and Emerging Diseases (RED)
Nanotexturing of Stainless Steel 316L by Electrochemical Etching for Biological Implants
ITDI
BIOMED
Nanostructured Herbal Extract of Momordica charantia (Bitter Melon/Ampalaya), Allium sativum (Garlic) and Curcuma longa L. (Turmeric) as Antidiabetic Agents